MPs Push for Wider NHS Access to Weight-Loss Injections

Vocabulary

Article

A cross-party group of British MPs has criticized the National Health Service's plan to provide Mounjaro, a weight-loss injection, to only 220,000 eligible patients by 2028. The Health Committee argues this figure represents merely 6% of those who qualify and reflects an unambitious approach to a medication that suppresses appetite. The committee's concern stems from a widening two-tier system: over one million people have already paid privately for weight-loss injections because the NHS rollout remains too slow, meaning access depends largely on wealth rather than medical need.